deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03711448

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (ULTRA)

Sponsor: Centre Hospitalier Universitaire Dijon

Conditions Patients Relapsing Refractory Giant Cell Arteritis
Interventions Blood samples prednisone and ustekinumab treatment prednisone treatment questionnaires
Updated 14 times since 2018 Last updated: Oct 3, 2024 Started: Jan 7, 2019 Primary completion: Sep 11, 2024 Completion: Sep 11, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Patients Relapsing Refractory Giant Cell Arteritis, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire Dijon and has accumulated 14 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2018 – ~Apr 2019 · 5 months · monthly snapshot~Apr 2019 – ~Nov 2019 · 7 months · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Oct 2020 · 8 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Mar 2024 · 16 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 20 months · monthly snapshot

Change History

14 versions recorded

  1. Nov 2024 — Present [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  2. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Nov 2022 — Mar 2024 [monthly]

    Recruiting PHASE2

▶ Show 9 earlier versions

  1. Jun 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  2. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  3. Jan 2021 — May 2022 [monthly]

    Recruiting PHASE2

  4. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  5. Feb 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  6. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE2

  7. Nov 2019 — Jan 2020 [monthly]

    Recruiting PHASE2

  8. Apr 2019 — Nov 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Nov 2018 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire Dijon
Data source: Centre Hospitalier Universitaire Dijon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations